The single antibody shot helps stop infants getting chest infections, such as pneumonia, for about six months.
A large study has now begun to find out whether nirsevimab should be offered to all babies in the UK.
Respiratory syncytial virus (RSV) is the main reason children under five end up in hospital. BBC News
No comments:
Post a Comment